Mabvax Therapeutics Holdings Stock Market Capitalization
MabVax Therapeutics Holdings fundamentals help investors to digest information that contributes to MabVax Therapeutics' financial success or failures. It also enables traders to predict the movement of MabVax Pink Sheet. The fundamental analysis module provides a way to measure MabVax Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MabVax Therapeutics pink sheet.
MabVax |
MabVax Therapeutics Holdings Company Market Capitalization Analysis
MabVax Therapeutics' Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current MabVax Therapeutics Market Capitalization | 1.02 M |
Most of MabVax Therapeutics' fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, MabVax Therapeutics Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
CompetitionBased on the recorded statements, the market capitalization of MabVax Therapeutics Holdings is about 1.02 M. This is 99.99% lower than that of the Healthcare sector and 99.98% lower than that of the Biotechnology industry. The market capitalization for all United States stocks is 99.99% higher than that of the company.
MabVax Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MabVax Therapeutics' direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of MabVax Therapeutics could also be used in its relative valuation, which is a method of valuing MabVax Therapeutics by comparing valuation metrics of similar companies.MabVax Therapeutics is currently under evaluation in market capitalization category among related companies.
MabVax Fundamentals
| Return On Equity | -819.66 | |||
| Return On Asset | -61.26 | |||
| Profit Margin | (223.49) % | |||
| Operating Margin | (208.49) % | |||
| Current Valuation | 4.11 M | |||
| Shares Outstanding | 9.25 M | |||
| Shares Owned By Insiders | 9.09 % | |||
| Shares Owned By Institutions | 1.79 % | |||
| Number Of Shares Shorted | 296.46 K | |||
| Price To Earning | (0.16) X | |||
| Price To Book | 63.90 X | |||
| Price To Sales | 0.50 X | |||
| Revenue | 4.7 M | |||
| Gross Profit | (7.54 M) | |||
| EBITDA | (9.64 M) | |||
| Net Income | (17.3 M) | |||
| Cash And Equivalents | 951.75 K | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 2.69 M | |||
| Current Ratio | 0.19 X | |||
| Cash Flow From Operations | (4.91 M) | |||
| Short Ratio | 1.94 X | |||
| Earnings Per Share | (2.05) X | |||
| Beta | 7.05 | |||
| Market Capitalization | 1.02 M | |||
| Total Asset | 15.1 M | |||
| Retained Earnings | (60.6 M) | |||
| Working Capital | 3.14 M | |||
| Current Asset | 7.44 M | |||
| Current Liabilities | 4.29 M | |||
| Z Score | -5.6 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in MabVax Pink Sheet
If you are still planning to invest in MabVax Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MabVax Therapeutics' history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |